$2.1 B

DPLO Mkt cap, 22-Jun-2018

$1.3 B

Diplomat Pharmacy Revenue Q1, 2018
Diplomat Pharmacy Gross profit (Q1, 2018)110.6 M
Diplomat Pharmacy Gross profit margin (Q1, 2018), %8.2%
Diplomat Pharmacy Net income (Q1, 2018)-450 K
Diplomat Pharmacy EBIT (Q1, 2018)8.7 M
Diplomat Pharmacy Cash, 31-Mar-20186 M

Diplomat Pharmacy Financials

Diplomat Pharmacy Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016

Revenue

2.2 b3.4 b4.4 b

Revenue growth, %

52%31%

Cost of goods sold

2.1 b3.1 b4.1 b

Gross profit

140.1 m263.2 m324.8 m

Gross profit Margin, %

6%8%7%

General and administrative expense

127.6 m217.3 m277.8 m

Operating expense total

127.6 m217.3 m277.8 m

EBIT

12.6 m45.9 m47.1 m

EBIT margin, %

1%1%1%

Interest expense

2.5 m5.2 m6.6 m

Pre tax profit

9.2 m41 m36.2 m

Income tax expense

(4.7 m)(16.2 m)(11.2 m)

Net Income

4.6 m24.8 m25 m

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

624.9 m808 m946.9 m995.9 m1.1 b1.2 b1.1 b1.1 b1.1 b1.3 b

Cost of goods sold

583.7 m738.3 m871.2 m916.6 m1 b1.1 b993.7 m1 b1 b1.2 b

Gross profit

41.1 m69.7 m75.8 m79.2 m83.3 m78.5 m85 m84.8 m85.3 m110.6 m

Gross profit Margin, %

7%9%8%8%8%7%8%8%8%8%

General and administrative expense

36.3 m62.5 m48.9 m54.2 m69.4 m77.1 m76.5 m80 m101.9 m

Operating expense total

36.3 m62.5 m48.9 m54.2 m69.4 m77.1 m76.5 m80 m101.9 m

EBIT

4.8 m7.2 m26.9 m25 m13.9 m1.4 m8.5 m4.8 m2.3 m8.7 m

EBIT margin, %

1%1%3%3%1%0%1%0%0%1%

Interest expense

321 k1.9 m1.5 m1.4 m1.5 m1.8 m2 m1.9 m2.1 m10.4 m

Pre tax profit

4.6 m5.4 m25.5 m23.7 m12.4 m(408 k)6.5 m2.9 m299 k(1.3 m)

Income tax expense

(2 m)(2.3 m)(9.8 m)(8.5 m)(4.1 m)3.2 m(2.3 m)544 k868 k

Net Income

2.7 m3.1 m15.7 m15.2 m8.3 m2.8 m4.2 m3.5 m961 k(450 k)

Diplomat Pharmacy Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016

Cash

18 m27.6 m8 m

Accounts Receivable

158.5 m254.7 m275.6 m

Inventories

110.7 m166 m215.4 m

Current Assets

291.1 m461 m519.8 m

PP&E

13.2 m16.5 m20.4 m

Goodwill

23.1 m256.3 m316.6 m

Total Assets

390.1 m1 b1.1 b

Accounts Payable

202.5 m296.6 m320.7 m

Current Liabilities

215.4 m371.9 m385.3 m

Total Liabilities

494.2 m

Common Stock

451.6 m503.8 m

Additional Paid-in Capital

9.9 m29.2 m33.3 m

Retained Earnings

5.4 m31.1 m76.3 m

Total Equity

168.7 m515.5 m613.7 m

Financial Leverage

2.3 x2 x1.8 x

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

162 m17.3 m15.7 m14.7 m7.9 m17.1 m16.6 m7.8 m6 m

Accounts Receivable

167.5 m257.9 m258.2 m268.4 m317.2 m289.2 m255.5 m279.6 m277.8 m

Inventories

109.8 m159.5 m153.3 m181 m182.2 m197 m200.3 m178.1 m195 m194.8 m

Current Assets

444.8 m452.7 m437.2 m492.3 m529.3 m528.8 m479.7 m476 m509.3 m544 m

PP&E

13.6 m14.2 m15 m17.5 m19.5 m20.1 m19.9 m21 m39.7 m

Goodwill

23.1 m250.5 m253.4 m256.3 m315.4 m315.4 m336.8 m358.2 m383 m835.6 m

Total Assets

544.8 m1 b984.2 m1 b1.1 b1.1 b1.1 b1.1 b1.2 b1.8 b

Accounts Payable

198.4 m265.6 m272 m291.7 m379.5 m332 m301.4 m307.7 m327.5 m393.2 m

Current Liabilities

212.7 m402.1 m358.5 m362.5 m424.9 m402.7 m339.2 m340.4 m381 m615.2 m

Total Liabilities

220.1 m532.3 m482.2 m478.8 m539 m516.9 m464.5 m463.8 m506.9 m1.1 b

Common Stock

299.9 m445.3 m448.7 m452.2 m499.5 m502.7 m507.4 m515.8 m525.2 m621.9 m

Preferred Stock

Additional Paid-in Capital

12.3 m11.9 m21.9 m30.6 m32.1 m32.8 m33.5 m35.4 m36.7 m40.9 m

Retained Earnings

8.2 m11.6 m27.6 m63.5 m72 m77.4 m80.7 m84.3 m85.3 m91.2 m

Total Equity

324.7 m472.9 m502 m549.6 m606.7 m613.4 m621.7 m635.5 m647.2 m754 m

Financial Leverage

1.7 x2.1 x2 x1.9 x1.9 x1.8 x1.7 x1.7 x1.8 x2.4 x

Diplomat Pharmacy Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016

Net Income

4.6 m24.8 m25 m

Depreciation and Amortization

30.8 m50 m

Accounts Receivable

158.5 m(50.8 m)(15.1 m)

Inventories

110.7 m(41.7 m)(44.3 m)

Accounts Payable

202.5 m43.2 m(5.9 m)

Cash From Operating Activities

8.8 m9.6 m31.3 m

Cash From Investing Activities

(311.6 m)(86 m)

Long-term Borrowings

(3 m)(6 m)

Cash From Financing Activities

291.8 m35 m

Interest Paid

3.9 m5.3 m

Income Taxes Paid

351 k728 k

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018

Net Income

2.7 m3.1 m15.7 m15.2 m8.3 m2.8 m4.2 m961 k(450 k)

Depreciation and Amortization

24 m

Accounts Receivable

167.5 m257.9 m258.2 m268.4 m317.2 m289.2 m255.5 m277.8 m21 k

Inventories

109.8 m159.5 m153.3 m181 m182.2 m197 m200.3 m195 m11.9 m

Accounts Payable

198.4 m265.6 m272 m291.7 m379.5 m332 m301.4 m327.5 m11.8 m

Cash From Operating Activities

48.6 m

Cash From Investing Activities

(2.9 m)

Long-term Borrowings

(76.9 m)

Cash From Financing Activities

(123.9 m)

Interest Paid

10.2 m

Diplomat Pharmacy Ratios

USDY, 2018

Financial Leverage

2.4 x
Report incorrect company information